Funding
Ubiquisys, the leading developer of 3G femtocells, has completed the second close of the funding round first announced in July, with a $5 million investment led by three Taiwanese companies: SerComm Corporation, UMC Capital Corporation and Pacific Venture Partners, with participation from existing investors Advent Venture Partners, Accel Partners and Atlas Venture.
The company says the investment reflects the growing importance of it ‘Femto-Engine’ business model, which frees operators and device manufacturers to fast-track their own designs for femtocells, small devices which improve connections to wireless networks from within homes and offices. Ubiquisys has strategic relationships with a number of Asian device manufacturers that have been instrumental in producing femtocells at for less than $100, the price point that enables operators to supply them for free.
Building on the company’s flagship deployment with SoftBank Mobile in Japan, the capital will be used to accelerate its momentum worldwide, particularly in the Americas.
Ubiquisys has also dealt with the number one concern among operators of interference problems between femtocells and the wider wireless network, through its adaptive Radio Resource Management system, which eliminates interference problems.
“Asia plays a leading role in the femtocell industry today, both in terms of product diversity and business model innovation,” said Chris Gilbert, CEO Ubiquisys. “We are delighted to be adding strategic investors who bring extra know-how to help Ubiquisys build on our strong international momentum.”
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
